Benlysta update - free webinar
The Lupus Foundation of America (LFA) invites those living with Lupus and interested in learning more about the results of the BENLYSTA (belimumab) studies to join them for a special Webinar on Monday, November 30, 2009 at 7 p.m. EST.
Dr. Joan T. Merrill- “The lupus community has waited for decades for one positive Phase 3 trial of an investigative drug developed for Lupus. Now we have two. Based on the data we now have in hand, we have cause for hope that belimumab may emerge as a significant new treatment for lupus,” said Joan T. Merrill, M.D., a study investigator, Program Chair, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, and Professor, Department of Medicine, University of Oklahoma Health Sciences Center.
Dr. Merrill will be the host the webinar on November 30th. She will summarize the results from the BENLYSTA studies and answer questions from attendees.
Learn more >>
Dr. Joan T. Merrill- “The lupus community has waited for decades for one positive Phase 3 trial of an investigative drug developed for Lupus. Now we have two. Based on the data we now have in hand, we have cause for hope that belimumab may emerge as a significant new treatment for lupus,” said Joan T. Merrill, M.D., a study investigator, Program Chair, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, and Professor, Department of Medicine, University of Oklahoma Health Sciences Center.
Dr. Merrill will be the host the webinar on November 30th. She will summarize the results from the BENLYSTA studies and answer questions from attendees.
Learn more >>
Tags: autoimmunity, benlysta, lfa, lupus, lupus research, medication, webinar
© 2009 Created by Marie
